Regenerative medicine is fast becoming a game changer in the treatment of diseases and has the attention of investors. The number of market approved cell and gene therapy treatments continues to grow, with a high number of trials, and other therapies seeking approval.
Within the region, the Singapore Government is pumping $80 million into programs for developing technologies to scale up production. Malaysia, Thailand and Indonesia have passed regulations to progress investment and development, and North Asia remains a magnet for new investment.
ASEAN’s pioneering forum on C> will bring in investors biotechs, big pharma, regulators, and technology leaders to canvass opportunities in this burgeoning sector.
Still have a question?